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Helicobacter pylori is the causative agent of most cases of gastritis. Once
acquired, H. pylori establishes chronic persistent infection; it is this long-term
infection that, in a subset ofpatients, leads to gastric or duodenal ulcer, gastric
cancer or gastric MALT lymphoma. All fresh isolates of H. pylori express sig-
nificant urease activity, which is essential to survival and pathogenesis of the
bacterium. A significant fraction of urease is associated with the surface of H.
pylori both in vivo and in vitro. Surface-associated urease is essential for H.
pylori to resist exposure to acid in the presence ofurea. The mechanism where-
by urease becomes associated with the surface of H. pyloni is unique. This
process, which we term "altruistic autolysis," involves release of urease (and
other cytoplasmic proteins) by genetically programmed autolysis with subse-
quent adsorption of the released urease onto the surface of neighboring intact
bacteria. To our knowledge, this is the first evidence of essential communal
behavior in pathogenic bacteria; such behavior is crucial to understanding the
pathogenesis ofH. pylori.
INTRODUCTION
Since the discovery ofHelicobacterpylori in 1982 [1], its critical role in many gas-
troduodenal diseases has become clear. H. pylori is the causative agent of most cases of
gastritis [2]. Once acquired, H. pylori establishes chronic persistent infection; it is this
long-term infection that, in a subset ofpatients, leads to gastric or duodenal ulcer, gastric
cancer or gastric MALT lymphoma [2-5].
H. pylori colonizes the human stomach, which, due to the highly acidic pH, is a hos-
tile environment for most microorganisms and as a result, is considered the first line of
defense against most gastrointestinal pathogens. It has been estimated that exposure to
gastric acid kills more than 99.9 percent of ingested Salmonella and Vibrio sp. [6]. H.
pylori survives in this acidic environment by producing abundant quantities of urease,
which hydrolyses urea into ammonia and C02, thought to result in generation of a pH-
neutral micro-environment.
Urease is not only an essential factor for colonization ofH. pylori, but contributes to
pathogenesis by diverse mechanisms. In addition, urease-based vaccines have proven effi-
cacious against Helicobacterinfection in animals and are now in clinical trials in humans.
In this review, we highlight available information concerning the structure, function
and subcellular localization of H. pylori urease. We place particular emphasis on the
unique mechanisms whereby urease becomes associated with the surface of H. pylori,
since surface-association of urease is crucial to survival of this important gastroduodenal
pathogen.
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GENETICS AND ENZYMOLOGY OF H. PYLORI UREASE
All fresh isolates ofH. pylori express significant urease activity, which is essential to
survival and pathogenesis of the bacterium [7-9]. Urease (urea amidohydrolase; EC
3.5.1.5) catalyzes the hydrolysis ofurea to yield ammonia and carbamate, which, in turn,
spontaneously decomposes to yield another molecule of ammonia and carbonic acid. In
solution, the released carbonic acid and the two molecules ofammonia are in equilibrium
with their deprotonated and protonated forms, respectively. The net effect of these reac-
tions is an increase in pH [10]. Ammonium, not ammonia, is the toxic form of the mole-
cule [10, 11]. Within the gastric lumen, it is thought that hydrolysis of urea generates
ammonia to counterbalance gastric acid, presumably forming a neutral microenvironment
surrounding H. pylori.
H. pylori urease has been purified to homogeneity; the enzyme is composed of a
heavy (60-62 kDa) and a light (27-30 kDa) subunit in a 1:1 molar ratio [8, 9]. With a Km
of0.2-0.5 mM [8, 9], H. pylori urease is well adapted to the low urea concentrations nor-
mally present within the stomach.
The specific activity ofurease in whole cell lysates ofH. pylori is higher than in other
urease-positive bacteria, in part because the specific activity of purified H. pylori urease
(1100-1500 U/mg) is relatively high, and because urease constitutes a large amount (6 to
10 percent) of the total protein of H. pylori [8, 9].
Nine genes have been identified in the urease gene cluster, similar to other urease-
producing bacterial species (reviewed in [10]). Only seven of these are thought to be
essential for urease expression and functional activity, however. The structural genes ureA
and ureB and accessory genes ureF, ureG and ureH are essential for enzyme activity [10].
By analogy with homologous genes in Klebsiella aerogenes and Protease mirabilis [12-
14], the accessory genes likely play a role in activation ofthe apoenzyme and insertion of
Ni2+ ions into the active site of the nascent enzyme during assembly.
Recombinant urease is optimally expressed when Ni2+ uptake is not inhibited and
when sufficient synthesis of urease subunits UreA and UreB is permitted [15]. A high-
affinity Ni2+ transport protein (NixA), which provides Ni2+ transport at low metal con-
centrations, is necessary for full activity of recombinant H. pylori urease [16, 17].
However, isogenic nixA deficient strains of H. pylori do exhibit urease activity, although
at reduced levels compared with strains possessing functional NixA protein [17], sug-
gesting that at least one additional Ni2+ uptake system is operational.
ROLE OF H. PYLORI UREASE IN COLONIZATION
Urease activity is essential for initiating colonization of the stomach of animal mod-
els by Helicobacter sp. Isogenic urease-negative mutants were unable to colonize gnoto-
biotic piglets regardless ofwhether the piglets had normal acid output [7] or had been ren-
dered achlorhydric [18]. In addition, isogenic urease-negative mutants of H. pylori failed
to colonize the stomach of nude mice [19], and isogenic urease-negative mutants of H.
mustelae failed to colonize ferrets [20].
Lack of colonization by urease-negative mutants is not due to inability to adhere to
the underlying mucosa, since urease-negative mutants are able to colonize gastric mucosa
biopsies at neutral pH in vitro [21], and urease per se is not thought to function as an
adhesin [22]. Further supporting the essential role of urease activity in colonization, urea
protects wildtype (urease-positive) H. pylori against acid (pH 2) in vitro. In contrast, H.
pylori exposed to the same pH levels in the absence of urea fails to survive [23, 24].
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DIRECT TOXICITY TO THE HOST
Ammonium generated by hydrolysis of urea by H. pylori urease is toxic to cultured
cells [25-27]. To demonstrate the cytotoxic effects ofurease, cell cultures ofa human gas-
tric adenocarcinoma cell line were incubated with H. pylori and supplemented with vari-
ous concentrations of urea [25]. Cell viability was found to be inversely proportional to
ammonia concentrations generated by urea hydrolysis. Cell viability was improved when
the urease inhibitor acetohydroxamic acid was added to the culture before exposure to H.
pylori [25].
HOST DAMAGE INDUCED BY THE IMMUNE RESPONSE
Urease activity has been implicated inimmune-mediated injury to the gastric mucosa.
H. pylori whole cells and sonicates stimulate an oxidative burst in human neutrophils [28,
29]. The urease enzyme per se can induce activation and recruitment of monocytes and
neutrophils, resulting in indirect damage to the gastric epithelium [30]. Water extracts of
H. pylori, known to contain urease in high concentration, can activate monocytes by a
lipopolysaccharide-independent pathway [31]. In vitro, stimulation of human monocytes
by H. pylori leads to secretion ofinflammatory cytokines and reactive oxygen intermedi-
ates, all of which may be involved in mediating the inflammatory response in the gastric
epithelium [28, 30, 31]
Urease from H. pylori can act as a chemotactic factor for human monocytes and neu-
trophils, causing local inflammation [32, 33]. Such chemotactic activity was present in
purified urease samples and could be inhibited by specific antibody to the UreB urease
subunit. Further, a 20-amino-acid peptide, based on the amino terminus ofthe UreB sub-
unit protein, also exhibited similar levels of chemotaxis in a micro-chamber test system
[31, 33]. By immunocytochemical staining, urease is closely associated with the crypt
cells in the lamina propria of individuals infected with H. pylori. Thus, urease released
fromH. pylori may become adsorbed into the mucosawhere it attracts leukocytes andpro-
motes mucosal inflammation [32, 33].
SUBCELLULAR LOCALIZATION OF UREASE AND HSPB
H. pylori appears unique in that both urease and HspB, a homolog ofthe GroEL heat
shock protein [34, 35], are major surface-associated proteins in late log phase bacteria as
has been documented by numerous investigators. These observations can be summarized
as follows. First, from 50 to 80 percent ofthe intact cell urease activity is recovered sim-
ply by washing the cells with deionized, distilled water [8] without adversely affecting
bacterial viability [8, 36]. Similarly, approximately 90 percent of the whole-cell urease
activity can be recovered by extraction with the detergent n-octylglucoside [37]. In addi-
tion, surface radioiodination demonstrates that urease and HspB are the major surface-
exposed proteins ofH. pylori [38]. Finally, immunogold and immunohistochemical local-
ization studies have also demonstrated surface-association of urease [39, 40]. However,
despite clear evidence that urease is located on the surface oflate log phase H. pylori, the
mechanisms whereby surface-association occurs are not immediately obvious.
UREASE AS A VACCINE AGAINST HELICOBACTER INFECTION
Because ofits association with the surface ofH. pylori and abundant quantity, urease
has been studied as a vaccine candidate against Helicobacter sp. by several groups [41-
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45]. H. pylori urease, when administered with appropriate adjuvants, such as choleratoxin
and the heat labile enterotoxin (LT)b ofE. coli, is able to protect mice from infection with
H.felis, a species closely related to H. pylori; the mouse-H.felis model mimics many fea-
tures of H. pylori-related human gastritis [45]. Orogastric administration of urease (with
adjuvant) can be used to eradicate existing infection or to prevent infection by experi-
mental challenge with H. felis [41-45]. Similarly, orogastric administration of H. pylori
urease (with adjuvant) can be used to eliminate existing infection with H. mustelae in the
ferret H. mustelae model [46]. These experiments indicate that in the mouse and ferret
models, antibodies to H. pylori urease have access to and are able to cross-react with H.
felis and H. mustelae urease. They further indicate that surface-exposed urease is essen-
tial for colonization ofmice and ferrets by H.felis and H. mustelae, respectively.
Urease is a promising candidate for human use. A double-blind placebo-controlled
clinical trial evaluated the safety ofurease in human volunteers infected naturally with H.
pylori [47]. In this phase I trial, orally-administered recombinant H. pylori urease was
well tolerated by the volunteers. However, since a mucosal adjuvant was not included, H.
pylori infection was not cured [47, 48]. A phase II clinical trial designed to monitor the
safety and immunogenicity ofrecombinant urease in the presence ofLT as mucosal adju-
vant is in progress [48].
There is indirect evidence that urease is surface-associated in vivo. First, the strong
immunological response mounted against urease and HspB in humans naturally infected
with H. pylori is consistent with a surface-associated or extracellular localization [11,49].
Second, pre-treatment of H. felis with monoclonal IgA against urease prevents infection
[50]. Finally, immunization ofanimals and humans induces mucosal secretory IgA direct-
ed against urease epitopes [44, 51].
MECHANISMS FOR SURFACE-ASSOCIATION OF UREASE
There are several reasons to suspect that anovel mechanism is responsible for surface
association ofH. pylori urease. First, urease is a cytoplasmic protein in all other bacteria
in which its subcellular location has been studied. Second, the nucleotide sequences ofthe
ureA and ureB structural genes of H. pylori urease do not contain an N-terminal signal
sequence [10, 52, 53]. Third, not only urease, but other proteins such as HspB, superox-
ide dismutase and catalase (which are typical cytoplasmic proteins in other gram negative
bacteria), have been shown to be surface-associated in H. pylori [49, 54, 55]. The gene
clusters encoding urease, HspB and catalase do not display the features normally associ-
ated with exported proteins [10, 35, 56]. Finally, H. pylori urease genes cloned in E. coli
produce active urease located in the cytoplasm. The production of recombinant urease is
enhanced by cloning a high affinity Ni2+ transporter gene, nixA, from H. pylori, indicat-
ing that enzymatically active recombinant urease can be assembled in the cytoplasm ofE.
coli. Thus, the urease ofH. pylori can be fully active when present strictly within the cyto-
plasmic compartment ofbacteria.
To obtain adequate bacterial yields for most experiments, H. pylori must be subcul-
tured in the laboratory. Using cryo-immunolocalization techniques, we have examined the
age- and culture condition-dependence of the subcellular localization of urease [49]. We
have demonstrated for the first time that urease is located strictly within the cytoplasmic
compartment inearly log (oneday) andmidlogphase (twodays) ofgrowth on agarplates.
Only in the late log phase of growth (three days) is some urease associated with the sur-
face of H. pylori. In contrast, after one day of growth in repeated subculture (the type of
culture typically used to inoculate animals in experimental challenges), significant
amounts of surface-associated urease are present. This surface-association of urease is
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accompanied by the appearance of extracellular wall fragments and amorphous debris
indicative ofbacterial autolysis. In these analyses, urease is notfoundwithin asingle com-
partment, but is present associated with the surface, free in the extracellular space and
within the cytoplasm of intact cells [49]. A variety of additional evidence supports the
occurrence of autolysis in H. pylori [49]. First, protein profiles of "water wash" prepara-
tions from whole cells are identical to those of intentionally-lysed bacteria. Second, sur-
face radioiodination ofwhole cells generates a profile similar to that observed in radioio-
dinated bacterial lysate preparations, suggesting that major cytoplasmic proteins liberated
due to autolysis have adsorbed to intact bacteria and, hence, mask the underlying intrin-
sic outer membrane proteins. Third, by using flurofamide, a potent, poorly-diffusible
inhibitor of urease activity, we have shown that both surface-associated and cytoplasmic
urease molecules are active enzymatically. The time course of localization of HspB and
catalase, two other typical cytoplasmic proteins, is essentially identical to that of urease.
These observations are incompatible with known mechanisms ofprotein export in bacte-
ria.
There are three known mechanisms of protein export in bacteria. The general secre-
tory pathway requires that the exported protein possess an N-terminal signal sequence,
which is removed during the process of secretion [57]. The DNA sequence data for ure-
ase, HspB and catalase do not reveal any N-terminal signal sequence [10, 35, 56]. The
general secretory pathway is the only protein export mechanism known to assemble and
export complex multimeric proteins; it is well known thatproteins exported by this mech-
anism are assembled in the periplasm, not within the cytoplasm [57].
The ABC transporter pathway requires the presence of two accessory proteins, an
ATPase and a specific transport protein that spans both the inner and outer membranes;
the genes for these accessory proteins are usually located within the same operon as is the
gene encoding the exported protein [58]. To our knowledge, no multi-subunit proteins are
secreted by this pathway.
The type III pathway of protein export has recently attracted much attention. This
pathway may be induced by bacterial contact with eukaryotic cells; the exported proteins
(which lack a typical N-terminal signal sequence) are often delivered directly to the target
cells. This pathway requires the presence of 12 or more accessory proteins that are high-
ly conserved across diverse bacterial species; such proteins are usually located in the bac-
terial membrane [59]. The exportedprotein, almost always comprised ofa single polypep-
tide chain, is complexed with a unique molecular chaperone which promotes proper con-
formational change only after the exported protein is released by the bacteria. There are
no examples oftransmembrane transport ofmulti-subunit proteins using this pathway.
Transporters analogous to theABC pathway ortypeIll accessory proteins are notpre-
sent in either the urease, HspB or catalase gene clusters. The strict cytoplasmic location
of active urease in early log phase H. pylori and in recombinant E. coli strongly argues
against the presence of individual molecular chaperones for urease structural proteins,
since such molecular chaperones would not allow assembly of active urease in the cyto-
plasm.
While there is no evidence to suggest that urease and HspB are translocated actively
onto the surface ofH. pylori, if a secretion system were to exist, it would require a vari-
ety of features that would be unique compared with other bacterial transport systems, as
we have discussed in detail previously [49, 60]. Such a secretion system would be non-
specific in nature, be induced only in late log-phase bacteria, be induced asynchronously
within individual bacteria and be capable of transporting large, fully assembled multi-
subunit proteins. Finally, the accumulation of cytoplasmic protein, as observed both in
vivo and in vitro, would suggest either that the hypothetical transport system can discrim-
inate between two populations ofproteins (those destined to remain within the cytoplasm
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versus those destined to be secreted) or that the rate of secretion is limited by the number
oftransporter molecules (resulting in "back-up" ofprotein in the cytoplasm prior to secre-
tion). Given the strong evidence supporting the bacterial autolysis theory, and the tremen-
dous constraints required for such a hypothetical secretion system, we believe that bacte-
rial autolysis followed by adsorption is the mechanism for surface association of urease
[49, 60].
We have recently performed immunolocalization studies of urease and HspB within
H. pylori present in gastric biopsies obtained from naturally-infected humans [60]. Urease
and HspB are present both on the surface and within the cytoplasm of H. pylori, similar
to the subcellular location of these proteins in late log phase bacteria in vitro. Thus, we
presume that the identical mechanisms responsible for surface association of urease and
HspB in vitro are also operative in vivo.
THE PATHOGENIC ROLE OF SURFACE-ASSOCIATED UREASE
Despite the fact that H. pylori colonize and grow in the human stomach where lumi-
nal pH may be 2.0 orless, the bacteria are not intrinsically resistant to acid. In vitro, it has
been shown that H. pylori are resistant to low pH only in presence ofurea [23, 24]. Thus,
urease activity is essential for bacterial survival. We have recently assessed the relative
contributions of cytoplasmic and surface-associated urease to acid resistance [61]. Early
log phase H. pylori (which possess only cytoplasmic urease) are unable to survive at low
pH despite the presence ofphysiological concentrations (5 mM) ofurea; such bacteria are
acid sensitive. In contrast, late log phase bacteria (which possess both cytoplasmic and
surface-associated urease activity) are resistant to acid in the presence of5 mM urea [61].
From these and related experiments, we conclude that surface-associated urease is essen-
tial to protect H. pylori from the low pH it normally encounters in the stomach.
ALTRUISTIC AUTOLYSIS
As noted above, surface-associated ureaseper se is essential to acid resistance ofH.
pylori [61]. We believe that surface-association of urease occurs by a novel mechanism.
Specifically, urease (and other cytoplasmic proteins) are released as a result of genetical-
ly programmed autolysis affecting a fraction of the bacteria. Released urease (and other
cytoplasmic proteins, notably HspB) then adsorb onto the surface of neighboring intact
bacteria, thereby permitting survival ofthe population at the cost ofindividual cell death.
We have coined the term "altruistic autolysis" to describe this process [62]. Since surface-
associated urease is essential for resistance ofH. pylori to acid, and since bacterial autol-
ysis is a prerequisite for surface-association ofurease, "altruistic autolysis" is an essential
feature ofthe pathogenesis of H. pylori (Figure 1).
In addition to urease and HspB, several typical cytoplasmic proteins are associated
with the surface of late log phase H. pylori. Using standard biochemical techniques to
recover membrane proteins, a variety ofproteins have been recovered from H. pylori that
ultimately have proven to be cytoplasmic proteins. Four such proteins include catalase,
originally described as an exoenzyme S-like adhesin [56], a hemagglutinin [63], bacteri-
oferritin [64] and a 26-kDa species-specific protein [65]. These observations support the
notion that multiple cytoplasmic proteins are released and bind to the surface ofintact H.
pylori.
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Figure 1. Keystepsinvolved in surface-association ofurease.A) Early logphasebacteriacontain
only cytoplasmic urease and HspB; B) bacteria undergo genetically-programmed autolysis, result-
ing in therelease ofurease and HspB into the surrounding environment; C) someofthereleasedure-
ase and HspB adsorbs to the surface ofneighboring intact bacteria, which, as a result, possess both
surface-adsorbed and cytoplasmic urease. The latter forms (C) can convert to coccoid forms (not
shown) or to bacillary forms in which urease and HspB are present within the cytoplasm only (A).
IMMUNE EVASION
Continual release of urease (and HspB) from bacteria undergoing autolysis in vivo
may provide a form ofcamouflage by binding to specific secretory IgA directed against
H. pylori, thereby allowing intact H. pylori to evade the immune system. By such a
mechanism, secretory IgA that binds to free urease and HspB released from H. pylori
would be unable to bind to intact bacteria [49, 62].
IS THERE A FUNCTIONAL ORANATOMIC NICHE FOR
EARLY LOG PHASE H. PYLORI?
Since surface-associated urease is required for resistance ofH. pylori to acid, inacti-
vation of surface-associated urease by specific inhibitors might be expected to clear
Helicobacter infection. In studies using the ferret-H. mustelae model, treatment of ani-
mals with flurofamide, a potent, poorly-diffusible urease inhibitor have failed to clear the
infection [66]. Inhibition of urease activity seems to eliminate most bacteria from the
stomach as evidenced by the marked decrease in urease activity detected post-treatment
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using a urea breath test. However, soon after treatment with urease inhibitors, the infec-
tion recurs [66]. Such observations suggest that there may be a "niche" in which early log
phase bacteria or coccoid forms (both forms express cytoplasmic but not surface-associ-
ated urease activity [49] reside). Whether such a functional niche corresponds to a specif-
ic anatomic niche (such as beneath the gastric mucous layer, where the pH approaches
neutrality [67]) is not known.
Our "altruistic autolysis" model predicts that a subpopulation of H. pylori exists in
vivo that contains cytoplasmic urease only. Because surface-associated urease is not pre-
sent, such a subpopulation would be expected to evade the effects ofurease inhibitors and
specific antibodies in vivo.
In summary, urease is an essential virulence factor ofH. pylori, which contributes to
pathogenesis by diverse mechanisms. Surface localization ofurease is mediated by "altru-
istic autolysis." Understanding altruistic autolysis and its ramifications are essential to
development of improved therapies and vaccines against H. pylori.
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